Clinical Trial Update: DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study [NA]

View source ↗

Summary

Update on Medtronic's DelIVery trial for pulmonary arterial hypertension (PAH); the study is currently active but not recruiting, with results posted on 2018-05…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Pulmonary Arterial Hypertension | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2018-05-04